NCT01905410View on ClinicalTrials.gov

Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Healthy
Interventions
DRUG

VVZ-149 Injection

VVZ-149 in water for injection

DRUG

placebo

water for injection

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Sungnam-Si

All Listed Sponsors
lead

Vivozon, Inc.

INDUSTRY

NCT01905410 - Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection | Biotech Hunter | Biotech Hunter